The Clorox Company (NYSE:CLX) Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC lowered its position in shares of The Clorox Company (NYSE:CLXGet Rating) by 14.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,008 shares of the company’s stock after selling 352 shares during the quarter. International Assets Investment Management LLC’s holdings in Clorox were worth $350,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CLX. Two Sigma Advisers LP acquired a new stake in Clorox during the third quarter valued at approximately $83,285,000. Macquarie Group Ltd. raised its position in shares of Clorox by 133.5% during the 3rd quarter. Macquarie Group Ltd. now owns 668,579 shares of the company’s stock worth $110,717,000 after purchasing an additional 382,213 shares during the period. Natixis Investment Managers International raised its position in shares of Clorox by 28,702.2% during the 3rd quarter. Natixis Investment Managers International now owns 317,976 shares of the company’s stock worth $52,660,000 after purchasing an additional 316,872 shares during the period. Allspring Global Investments Holdings LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $48,724,000. Finally, Nuance Investments LLC raised its position in shares of Clorox by 250.8% during the 4th quarter. Nuance Investments LLC now owns 351,858 shares of the company’s stock worth $61,350,000 after purchasing an additional 251,543 shares during the period. Hedge funds and other institutional investors own 77.28% of the company’s stock.

Shares of NYSE CLX opened at $157.09 on Tuesday. The Clorox Company has a twelve month low of $127.02 and a twelve month high of $191.75. The company has a current ratio of 0.71, a quick ratio of 0.40 and a debt-to-equity ratio of 3.28. The company has a market capitalization of $19.33 billion, a price-to-earnings ratio of 42.57, a PEG ratio of 5.44 and a beta of 0.18. The firm has a 50-day moving average of $143.58 and a two-hundred day moving average of $157.23.

Clorox (NYSE:CLXGet Rating) last issued its quarterly earnings results on Monday, May 2nd. The company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.34. Clorox had a net margin of 6.44% and a return on equity of 92.98%. During the same period in the prior year, the business posted $1.62 earnings per share. As a group, research analysts predict that The Clorox Company will post 4.16 earnings per share for the current year.

CLX has been the topic of a number of research reports. Zacks Investment Research cut Clorox from a “hold” rating to a “strong sell” rating and set a $124.00 price target on the stock. in a research report on Tuesday, February 8th. DA Davidson dropped their price target on Clorox from $127.00 to $123.00 in a research report on Tuesday, May 3rd. Barclays lowered their target price on Clorox from $132.00 to $117.00 and set an “underweight” rating on the stock in a research report on Friday, April 1st. JPMorgan Chase & Co. raised their target price on Clorox from $123.00 to $126.00 in a research report on Thursday, April 14th. Finally, The Goldman Sachs Group lowered their target price on Clorox from $145.00 to $127.00 in a research report on Tuesday, March 29th. Ten analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Sell” and a consensus price target of $145.67.

In other Clorox news, COO Eric H. Reynolds sold 585 shares of the business’s stock in a transaction dated Monday, May 9th. The stock was sold at an average price of $154.83, for a total transaction of $90,575.55. Following the sale, the chief operating officer now owns 17,289 shares in the company, valued at approximately $2,676,855.87. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.58% of the stock is currently owned by corporate insiders.

Clorox Company Profile (Get Rating)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXGet Rating).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.